Peter Powchik, SVP Clinical Development & Reg at REGENERON PHARMACEUTICALS INC (REGN), sold 15,144 shares at $138.59 ($2.1M) on 2012-11-08, disclosed to the SEC on 2012-11-09.
Open-market sale of $2.1M REGN by SVP Clinical Development & Reg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.59 | 14,244 | $2.0M | 94.0% |
| 2 | $139.05 | 900 | $125K | 6.0% |
| Total | $138.62 avg | 15,144 | $2.1M | 100% |
| Filing → |
| REGN | SELL | 2014-01-03 | $5.7M | — | Filing → |
| REGN | SELL | 2013-12-20 | $2.5M | — | Filing → |
| REGN | SELL | 2013-12-17 | $2K | — | Filing → |